Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Newsrooms everywhere are grappling with the opportunities and risks of using generative AI tools. The Poynter Institute aims to support journalists in using these tools ethically and responsibly, in ...

Pakistan strikes $4 billion deal to sell weapons to Libyan force, officials say Pakistan has reached a deal worth over $4 billion to sell military equipment to the Libyan National Army, four Pakistani ...

Morningstar Data+Analytics combines our renowned independent research and ratings with coverage and analysis of the expanding universe of investment opportunities. Reveal actionable insights about a ...